Skip to main content
ENDO 2026 Main banner

Topic: Diabetes and Vascular Disease
Session Type: Symposium

SY27 - Stopping Prediabetes in Its Tracks: Preventing Both T1D and T2D

Sunday, June 14, 2026
10:30 AM - 12:00 PM CT
Location: Room W375B

Disclosure(s):
Chantal Mathieu, MD,PhD: No financial relationships to disclose
William H. Herman, MD, MPH: No financial relationships to disclose
Carmella Evans-Molina, MD, PhD: No relevant disclosure to display
Ramachandra Naik, MD: No financial relationships to disclose

Prediabetes increases the risk of not only diabetes but also atherosclerotic cardiovascular disease. In the United States, one in three adults have prediabetes. This symposium will review prediabetes prevalence, cardiovascular disease risk and lifestyle and medication options for management of prediabetes.

Presentations:

  • 10:30 AM - 10:52 AM CT
    Delaying the Onset of Type 1 Diabetes: Teplizumab and Beyond

    Symposium Speaker: Carmella Evans-Molina, MD, PhD – Indiana University

  • 10:52 AM - 11:14 AM CT
    Insights from National and International Type 2 Diabetes Prevention Programs

    Symposium Speaker: William H. Herman, MD, MPH – University of Michigan

  • 11:14 AM - 11:36 AM CT
    INNODIA and the Future of Type 1 Diabetes: From Biomarkers to Prevention

    Symposium Speaker: Chantal Mathieu, MD,PhD – KU Leuven

  • 11:36 AM - 11:58 AM CT
    The Silent Threat: Prediabetes, Cardiovascular Risk, and the Need for Early Action

    Symposium Speaker: Ramachandra Naik, MD (he/him/his) – NYU Langone Health